Index to volume 2 (no. 1-10) (1999) for health professionals who care for cancer patients VOLUME 2 Jan-December 1999 No. 1 ............................................. January No. 6..........................................................June No. 2 ............................................February No. 7...............................................July-August No. 3 .............................................. March No. 8...................................September-October No. 4 ...................................................April No. 9................................................. November No. 5 ...................................................May No. 10............................................... December SUBJECT INDEX A BRAVAC cyclophosphamide dose modification Aminoglutethimide (Cytadren®) Discontinued for hepatic dysfunction deleted Protocol Drug Update, vol 2 (3) Mar Update, vol 2 (8) Sep-Oct Antiem-A deleted (replaced by SCNAUSEA) BRAVCAF cyclophosphamide dose modification Protocol Update, vol 2 (9) Nov for hepatic dysfunction deleted Protocol Antiem-B deleted (replaced by SCNAUSEA) Update, vol 2 (8) Sep-Oct Protocol Update, vol 2 (9) Nov BRAVCAP Protocols, vol 2 (5) May BRAVCLOD Protocols, vol 2 (5) May; Protocol B Update, vol 2 (8) Sep-Oct Baseline CBC for Chemotherapy, vol 2 (7) Jul- BRAVCMF cyclophosphamide dose Aug modification for hepatic dysfunction deleted BCG Interchangeability Drug Update, vol 2 (8) Protocol Update, vol 2 (8) Sep-Oct Sep-Oct; Drug Update, vol 2 (10) Dec BRAVCMFO cyclophosphamide dose Benzydamine Pharmacare Authorisation Drug modification for hepatic dysfunction deleted Update, vol 2 (8) Sep-Oct Protocol Update, vol 2 (8) Sep-Oct BRAJAC cyclophosphamide dose modification BRAVDOC Protocol Update, vol 2 (2) Feb; Pre- for hepatic dysfunction deleted Protocol printed orders, vol 2 (3) Mar Update, vol 2 (8) Sep-Oct BRAVLEN deleted Protocol Update, vol 2 (8) BRAJCAF cyclophosphamide dose modification Sep-Oct for hepatic dysfunction deleted Protocol BRAVNAV Protocol Update, vol 2 (7) Jul-Aug; Update, vol 2 (8) Sep-Oct Protocol Update, vol 2 (8) Sep-Oct BRAJCEF Protocols, vol 2 (5) May; Patient BRAVPAM Protocol Update, vol 2 (7) Jul-Aug; Handouts, vol 2 (5) May Protocol Update, vol 2 (8) Sep-Oct BRAJCMF cyclophosphamide dose modification BRAVTAX Protocol Update, vol 2 (4) Apr; for hepatic dysfunction deleted Protocol Protocol Update, vol 2 (8) Sep-Oct Update, vol 2 (8) Sep-Oct (U)BRAVTR Protocol Update, vol 2 (3) Mar; BRAJCMFO cyclophosphamide dose Protocol Update, vol 2 (8) Sep-Oct; revised modification for hepatic dysfunction deleted Protocol Update, vol 2 (9) Nov Protocol Update, vol 2 (8) Sep-Oct British Columbia Cancer Agency Provincial Systemic Therapy Program Update Index to Vol. 2 (No. 1-10) 1999 SUBJECT INDEX (U)BRAVTRAP replaces UBRAVTRPA Protocol CNPLATFU deleted Protocols, vol 2 (5) May Update, vol 2 (8) Sep-Oct (U)CNTEMOZ Protocol Update, vol 2 (10) Dec BRAVTRAP replaces UBRAVTRAP Protocol CNVCD2 deleted (replaced by CNCCV) Update, vol 2 (Sup 1) Nov Protocol Update, vol 2 (9) Nov (U)BRAVTRPA Protocol Update, vol 2 (3) Mar; Communities Oncology Network Annual replaced by (U)BRAVTRAP Protocol Meeting Continuing Education, vol 2 (8) Update, vol 2 (8) Sep-Oct Sep-Oct; Continuing Education, vol 2 (9) BRINFCAF cyclophosphamide dose Nov modification for hepatic dysfunction deleted Cyclophosphamide Cancer Drug Manual, vol 2 Protocol Update, vol 2 (8) Sep-Oct (8) Sep-Oct BRLA2 cyclophosphamide dose modification for Cyproterone 50 mg tablets Pharmacy Contract hepatic dysfunction deleted Protocol Update, vol 2 (5) May Update, vol 2 (8) Sep-Oct Bundle proposal for irinotecan (Camptosar®) D and epirubicin solution (Pharmorubicin Delisting Operational Supplies Benefit Drug list, PFS®) from Pharmacia and Upjohn vol 2 (3) Mar accepted BCHS Contract, vol 2 (3) Mar; vol Dexamethasone Patient Handouts, vol 2 (3) Mar 2 (4) Apr; Protocols, vol 2 (5) May Diet and Cancer: Looking Beyond 2000 Continuing Education, vol 2 (6) Jun C Diethylstilbestrol (DES) Shortage Drug Update, Capecitabine - Warfarin Interaction Drug vol 2 (7) Jul-Aug; Drug Update, vol 2 (9) Nov Update, vol 2 (3) Mar; Benefit Drug List, vol 2 (5) May; Patient Handouts, vol 2 (5) May; Docetaxel (Taxotere®) Requires non-PVC Patient Handouts, vol 2 (10) Dec Equipment Drug Update, vol 2 (2) Feb; Patient Handouts, vol 2 (3) Mar Carboplatin and Paclitaxel Benefit Drug List, vol 2 (2) Feb Caring for the Patient Receiving E Chemotherapy: Course & Practicum Nursing Emergency Aid Program, vol 2 (6) Jun Practice, vol 2 (3) Mar Etoposide Infusions Drug Update, vol 2 (4) Apr; Carmustine wafer (Gliadel®) Health Canada IV 20 mg/ml Pharmacy Contract Update, vol Approvals, vol 2 (3) Mar 2 (5) May CEF Benefit Drug List, vol 2 (5) May Chemotherapy Extravasation Policy (Patient F Care Policy III-20) Provincial Systemic (New) Fax number for "Undesignated Therapy Program, vol 2 (9) Nov Indications", vol 2 (6) Jun Clinical Training Awards Continuing Education, Filgrastim (G-CSF) Nursing Practice Tips, vol 2 vol 2 (3) Mar (8) Sep-Oct; (G-CSF, Neupogen®)Nursing Clodronate Benefit Drug List, vol 2 (5) May; Practice Tips, vol 2 (9) Nov Patient Handouts, vol 2 (5) May; Focus On, Fludarabine Benefit Drug List, vol 2 (5) May; vol 2 (5) May Drug Update, vol 2 (8) Sep-Oct CNCCV replaces CNVCD2 Protocol Update, vol 5-Fluorouracil 50 mg/ml Pharmacy Contract 2 (9) Nov Update, vol 2 (5) May; Bulk Vials Drug CNFUR96 deleted Protocols, vol 2 (5) May Update, vol 2 (7) Jul-Aug (U)CNIME Protocol Update, vol 2 (9) Nov Formestane Drug Update, vol 2 (8) Sep-Oct CNLOGRA deleted Protocols, vol 2 (5) May British Columbia Cancer Agency Provincial Systemic Therapy Program Update Index to Vol. 2 (No. 1-10) 1999 SUBJECT INDEX G GOOVCATM Protocol Update, vol 2 (1) Jan; vol (Filgrastim) G-CSF Nursing Practice Tips, vol 2 2 (4) Apr; Protocol Update, vol 2 (8) Sep- (8) Sep-Oct Oct; replaced GOOVMHI Protocol Update, GIA Protocol Update, vol 2 (1) Jan vol 2 (9) Nov GIEFUP Protocol Update, vol 2 (7) Jul-Aug; GOOVCATX Protocol Update, vol 2 (1) Jan; Protocol Update, vol 2 (8) Sep-Oct Protocol Update, vol 2 (2) Feb; vol 2 (4) Apr; Protocol Update, vol 2 (8) Sep-Oct GIENDO1 Protocol Update, vol 2 (1) Jan GOOVMHI deleted (replaced by a GOOVCATM) GIENDO2 Protocol Update, vol 2 (1) Jan; Protocol update, vol 2 (9) Nov Protocol Update, vol 2 (4) Apr GOOVTAX3 Protocol Update, vol 2 (3) Mar; vol GIFFAD Protocol Update, vol 2 (1) Jan 2 (4) Apr; Protocol Update, vol 2 (8) Sep-Oct GIFUA Protocol Update, vol 2 (1) Jan; GOOVTOP Protocols, vol 2 (5) May Protocols, vol 2 (5) May, revised Protocol Update, vol 2 (9) Nov (U)GOOVTOP Protocol Update, vol 2 (4) Apr; reclassified to Class II Protocols, vol 2 (5) GIFUC Protocol Update, vol 2 (1) Jan; revised May Protocol Update, vol 2 (9) Nov Goserelin (Zoladex®) injections Nursing GIFUFA Protocol Update, vol 2 (1) Jan Practice Tips, vol 2 (9) Nov GIFUINF Protocol Update, vol 2 (1) Jan Granisetron Pharmacare Authorisation Drug (U)GIFUIP Protocol Update, vol 2 (10) Dec Update, vol 2 (9) Nov GIFUL deleted Protocol Update, vol 2 (6) Jun GUBCG Protocol Update, vol 2 (9) Nov GIFUR2 Protocol Update, vol 2 (1) Jan GUBCV Protocol Update, vol 2 (8) Sep-Oct GIIR Protocol Update, vol 2 (1) Jan; Protocol GUBEP Protocol Update, vol 2 (2) Feb; Protocol Update, vol 2 (7) Jul-Aug Update, vol 2 (8) Sep-Oct; Protocol Update, (U)GIIRNALT Protocol Update, vol 2 (3) Mar vol 2 (10) Dec GIFUIP Protocol Update, vol 2 (3) Mar GUBMVAC renamed GUMVAC Protocol GIOCTLAR Protocol Update, vol 2 (7) Jul-Aug Update, vol 2 (8) Sep-Oct GIPGEM Protocol Update, vol 2 (1) Jan GUBP Protocol Update, vol 2 (8) Sep-Oct GIRAI Protocol Update, vol 2 (1) Jan GUBPV Protocol Update, vol 2 (8) Sep-Oct GIRALT Protocol Update, vol 2 (1) Jan; GUCMV Protocol Update, vol 2 (8) Sep-Oct Protocols, vol 2 (5) May GUEMCYT Protocol Update, vol 2 (8) Sep-Oct GIRFLOW, Protocol Update, vol 2 (2) Feb GUEP Protocol Update, vol 2 (8) Sep-Oct; GIRLAIFF Protocol Update, vol 2 (3) Mar Protocol Update, vol 2 (10) Dec Glass Ampoules Nursing Practice Tips, vol 2 (7) GUHIPE2 deleted Protocol Update, vol 2 (8) Jul-Aug Sep-Oct (Carmustine wafer) Gliadel® Health Canada GUKIFN Protocol Update, vol 2 (9) Nov Approvals, vol 2 (3) Mar GUMVAC (formerly GUBMVAC) Protocol GOCAT Preprinted Orders, vol 2 (1) Jan Update, vol 2 (8) Sep-Oct GOCXCISR Protocol Update, vol 2 (4) Apr; GUMXP Protocol Update, vol 2 (2) Feb; renamed Protocols, vol 2 (5) May renamed GUPMX Protocol Update, vol 2 (8) GOCXRADC Protocols, vol 2 (5) May Sep-Oct GOENDCAT Protocol Update, vol 2 (2) Feb; vol GUPM Protocol Update, vol 2 (8) Sep-Oct 2 (4) Apr; Protocol Update, vol 2 (8) Sep-Oct GUPMX (formerly GUMXP) Protocol Update, vol GOSMCC2 Protocol Update, vol 2 (9) Nov 2 (8) Sep-Oct GUVEIP Protocol Update, vol 2 (8) Sep-Oct British Columbia Cancer Agency Provincial Systemic Therapy Program Update Index to Vol. 2 (No. 1-10) 1999 SUBJECT INDEX GUVIP2 Protocol Update, vol 2 (8) Sep-Oct; L Protocol Update, vol 2 (10) Dec (Phase III Double Blind Study of) Letrozole versus Placebo in Women with Primary H Breast Cancer Completing Five or More HER-2 neu Testing Hot Topics, vol 2 (3) Mar Years of Adjuvant Tamoxifen (NCIC CTG (Trastuzumab) Herceptin® Hot Topics, vol 2 (3) MA17) Clinical Trial Update, vol 2 (2) Feb Mar; Patient Handouts, vol 2 (5) May; Drug LUALTL cyclophosphamide dose modification Update, vol 2 (8) Sep-Oct for hepatic dysfunction deleted Protocol HNDE Protocol Update, vol 2 (7) Jul-Aug Update, vol 2 (8) Sep-Oct HNE +/- C deleted Protocol Update, vol 2